Elutia (NASDAQ:ELUT – Get Free Report) is set to release its earnings data after the market closes on Thursday, May 9th. Persons that wish to listen to the company’s earnings conference call can do so using this link.
Elutia (NASDAQ:ELUT – Get Free Report) last announced its earnings results on Thursday, March 7th. The company reported ($0.66) earnings per share for the quarter. The business had revenue of $5.88 million for the quarter.
Elutia Stock Up 1.0 %
Shares of ELUT opened at $2.90 on Wednesday. The company has a market cap of $70.38 million, a price-to-earnings ratio of -1.37 and a beta of 0.56. Elutia has a twelve month low of $1.10 and a twelve month high of $4.19. The company has a 50 day moving average of $3.12 and a two-hundred day moving average of $2.73.
Elutia Company Profile
Elutia Inc, a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators.
Recommended Stories
- Five stocks we like better than Elutia
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Garmin Navigates to New Highs Driven By Wearables Trend
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- How to Calculate Options Profits
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Elutia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elutia and related companies with MarketBeat.com's FREE daily email newsletter.
